This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A discussion of Nexletol (Bempedoic acid) and CLEAR Cardiovascular Outcome Trial ahead of detailed data at ACC

Ticker(s): ESPR

Who's the expert?

Institution: Private Practice (NJ)

  • Non-invasive cardiologist in Private practice for 16+ years; fellowship trained at Drexel University College of Medicine.
  • Manages 250 patients/month with hyperlipidemia (~75 of which need additional therapies beyond statins).

Interview Goal
Discuss current use of Nexletol and potential for further use depending on strength of CVOT

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.